Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer

Journal of Surgical Oncology

Volumn 100, Issue 5, 2009, Pages 382-386

  Chen, Yan Bo ^a   Jiang, Chuan Tao ^b   Zhang, Guo Qiang ^a   Wang, Jin Song ^a   Pang, Da ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; HABP1; Metastasis; Prognosis

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CANCER TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; UPREGULATION;

AXILLA; BREAST; BREAST NEOPLASMS; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MITOCHONDRIAL PROTEINS; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE;

EID: 70349238709     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21329     Document Type: Article

References (34)

1. McArthur HL, Hudis CA: Breast cancer chemotherapy. Cancer J 2007;13:141-147.
2. Toole BP: Hyaluronan: From extracellular glue to pericellular cue. Nat Rev Cancer 2004;4:528-539.
3. Ghatak S, Misra S, Toole BP: Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002;277:38013-38020. (Pubitemid 35154652)
4. Auvinen P, Tammi R, Parkkinen J, et al.: Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000;156: 529-536. (Pubitemid 30643808)
5. Gupta S, Batchu RB, Datta K: Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface. Eur J Cell Biol 1991;56:58-67.
6. Gupta S, Datta K: Possible role of hyaluronectin on cell adhesion in rat histiocytoma. Exp Cell Res 1991;195:386-394. (Pubitemid 121006338)
7. Ranganathan S, Ganguly AK, Datta K: Evidence for presence of hyaluronan binding protein on spermatozoa and its possible involvement in sperm function. Mol Reprod Dev 1994;38:69-76. (Pubitemid 24139860)
8. Rao CM, Deb TB, Datta K: Hyaluronic acid induced hyaluronic acid binding protein phosphorylation and inositol triphosphate formation in lymphocytes. Biochem Mol Biol Int 1996;40:327-337.
9. Rao CM, Deb TB, Gupta S, et al.: Regulation of cellular phosphorylation of hyaluronan binding protein and its role in the formation of second messenger. Biochim Biophys Acta 1997; 1336:387-393. (Pubitemid 27467039)
10. Parle-McDermott A, McWilliam P, Tighe O, et al.: Serial analysis of gene expression identifies putative metastasis-associated transcripts in colon tumour cell lines. Br J Cancer 2000; 83:725-728. (Pubitemid 30694480)
11. Rubinstein DB, Stortchevoi A, Boosalis M, et al.: Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells. Int J Cancer 2004;110:741-750. (Pubitemid 38746033)
12. Ghosh I, Chowdhury AR, Rajeswari MR, et al.: Differential expression of Hyaluronic Acid Binding Protein 1 (HABP1)/P32/C1QBP during progression of epidermal carcinoma. Mol Cell Biochem 2004;267:133-139. (Pubitemid 39562393)
13. Fogal V, Zhang L, Krajewski S, et al.: Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res 2008;68:7210-7218.
14. Majumdar M, Datta K: Assignment of cDNA encoding hyaluronic acid-binding protein 1 to human chromosome 17p12-p13. Genomics 1998;51:476-477. (Pubitemid 28413218)
15. Deb TB, Datta K: Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. J Biol Chem 1996;271:2206-2212.
16. Das S, Deb TB, Kumar R, et al.: Multifunctional activities of human fibroblast 34-kDa hyaluronic acid-binding protein. Gene 1997;190:223-225. (Pubitemid 27214289)
17. Krainer AR, Mayeda A, Kozak D, et al.: Functional expression of cloned human splicing factor SF2: Homology to RNA-binding proteins, U170K, and Drosophila splicing regulators. Cell 1991;66:383-394.
18. Ghebrehiwet B, Lim BL, Peerschke EI, et al.: Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med 1994;179:1809-1821.
19. Soltys BJ,KangD,Gupta RS: Localization of P32 protein (gC1q-R) in mitochondria and at specific extramitochondrial locations in normal tissues. Histochem Cell Biol 2000;114:245-255.
20. Brokstad KA, Kalland KH, Russell WC, et al.: Mitochondrial protein p32 can accumulate in the nucleus. Biochem Biophys Res Commun 2001;281:1161-1169.
21. Sengupta A, Banerjee B, Tyagi RK, et al.: Golgi localization and dynamics of hyaluronan binding protein 1 (HABP1/p32/C1QBP) during the cell cycle. Cell Res 2005;15:183-186. (Pubitemid 41653941)
22. Chowdhury AR, Ghosh I, Datta K: Excessive reactive oxygen species induces apoptosis in fibroblasts: Role of mitochondrially accumulated hyaluronic acid binding protein 1 (HABP1/p32/gC1qR). Exp Cell Res 2008;314:651-667.
23. Peerschke EI, Ghebrehiwet B: The contribution of gC1qR/p33 in infection and inflammation. Immunobiology 2007;212:333-342.
24. Meenakshi J, Anupama, Goswami SK, et al.: Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in normal fibroblast cells perturbs its growth characteristics and induces apoptosis. Biochem Biophys Res Commun 2003;300: 686-693. (Pubitemid 36268891)
25. Sunayama J, Ando Y, Itoh N, et al.: Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32. Cell Death Differ 2004;11:771-781. (Pubitemid 39023123)
26. Kamal A, Datta K: Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis. Apoptosis 2006;11:861-874. (Pubitemid 43876853)
27. Bilder D: Epithelial polarity and proliferation control: Links from the Drosophila neoplastic tumor suppressors. Genes Dev 2004;18:1909-1925.
28. Igaki T, Pagliarini RA, Xu T: Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol 2006;16:1139-1146. (Pubitemid 43815753)
29. Bialucha CU, Ferber EC, Pichaud F, et al.: p32 is a novel mammalian Lgl binding protein that enhances the activity of protein kinase Czeta and regulates cell polarity. J Cell Biol 2007;178:575-581. (Pubitemid 47267270)
30. Ghebrehiwet B, Peerschke EI: Structure and function of gC1q-R: A multiligand binding cellular protein. Immunobiology 1998; 199:225-238. (Pubitemid 28404344)
31. Peterson KL, Zhang W, Lu PD, et al.: The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: Subcellular distribution and immunochemical characterization. Clin Immunol Immunopathol 1997;84:17-26. (Pubitemid 27293540)
32. Rozanov DV, Ghebrehiwet B, Postnova TI, et al.: The hemopexinlike C-terminal domain of membrane type 1 matrix metalloproteinase regulates proteolysis of a multifunctional protein, gC1qR. J Biol Chem 2002;277:9318-9325. (Pubitemid 34953015)
33. Laakkonen P, Akerman ME, Biliran H, et al.: Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci USA 2004;101:9381-9386. (Pubitemid 38812883)
34. Von Maltzahn G, Ren Y, Park JH, et al.: In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem 2008; 19:1570-1578.